| Company Name | Whan In Pharm. Co., Ltd. | Date Founded | June 5th, 1978 |
|---|---|---|---|
| Date Listed | July 3rd, 1996 | Chief Executive Officers | Chairman Kwangsik Lee, CEO & President Wonbum Lee |
| Representative Business Field |
Drug Manufacturing and Sales | Total Stocks Issued | 18,600,070 shares (Face Value: KRW 500) |
| Capital | KRW 9.7 Billion | Date of Settlement | December 31st |
| Headquarter's Address | 8F~11F, Whanin Building, 11, Beobwon-ro 6-gil, Songpa-gu, Seoul | Primary Phone | 02-405-3000 |
| Sector | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Ethical Drug | 99.6% | 98.5% | 99.4% | 98.7% | 98.9% |
| Over-the-counter Drug | 0.4% | 0.2% | 0.2% | 0.4% | 0.4% |
| Others | - | - | 0.4% | 0.9% | 0.7% |
| Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
[Unit: Million KRW]
| Category | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Central Nervous System |
141,936 |
144,182 |
155,251 |
176,808 |
206,412 |
Cardiovascular |
10,428 |
10,904 |
12,052 |
12,029 |
12,102 |
Gastrointestinal |
3,967 |
4,719 |
5,299 |
5,309 |
5,050 |
Osteoporosis |
4,390 |
4,911 |
4,189 |
4,180 |
3,046 |
Analgesics |
4,178 |
4,890 |
6,023 |
16,043 |
23,011 |
Others |
6,428 |
7,478 |
11,444 |
13,874 |
8,348 |
Total |
171,327 |
177,084 |
194,258 |
228,243 |
257,969 |
